Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone
Suxiao Jiuxin Pill (SJP) is a well-known traditional Chinese medicine drug used to manage heart diseases. This study aimed at determining the pharmacological effects of SJP in acute myocardial infarction (AMI), and the molecular pathways its active compounds target to induce coronary artery vasorela...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_ff899674a08b4c1c94964d0acdedbd07 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Sa Li |e author |
700 | 1 | 0 | |a Jiaguo Zhan |e author |
700 | 1 | 0 | |a Yucheng Wang |e author |
700 | 1 | 0 | |a Patrick Kwabena Oduro |e author |
700 | 1 | 0 | |a Felix Boahen Owusu |e author |
700 | 1 | 0 | |a Jiale Zhang |e author |
700 | 1 | 0 | |a Ling Leng |e author |
700 | 1 | 0 | |a Ling Leng |e author |
700 | 1 | 0 | |a Ruiqiao Li |e author |
700 | 1 | 0 | |a Ruiqiao Li |e author |
700 | 1 | 0 | |a Shujie Wei |e author |
700 | 1 | 0 | |a Jun He |e author |
700 | 1 | 0 | |a Jun He |e author |
700 | 1 | 0 | |a Qilong Wang |e author |
700 | 1 | 0 | |a Qilong Wang |e author |
700 | 1 | 0 | |a Qilong Wang |e author |
700 | 1 | 0 | |a Qilong Wang |e author |
245 | 0 | 0 | |a Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone |
260 | |b Frontiers Media S.A., |c 2023-05-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2023.1104243 | ||
520 | |a Suxiao Jiuxin Pill (SJP) is a well-known traditional Chinese medicine drug used to manage heart diseases. This study aimed at determining the pharmacological effects of SJP in acute myocardial infarction (AMI), and the molecular pathways its active compounds target to induce coronary artery vasorelaxation. Using the AMI rat model, SJP improved cardiac function and elevated ST segment. LC-MS and GC-MS detected twenty-eight non-volatile compounds and eleven volatile compounds in sera from SJP-treated rats. Network pharmacology analysis revealed eNOS and PTGS2 as the key drug targets. Indeed, SJP induced coronary artery relaxation via activation of the eNOS-NO pathway. Several of SJP's main compounds, like senkyunolide A, scopoletin, and borneol, caused concentration-dependent coronary artery relaxation. Senkyunolide A and scopoletin increased eNOS and Akt phosphorylation in human umbilical vein endothelial cells (HUVECs). Molecular docking and surface plasmon resonance (SPR) revealed an interaction between senkynolide A/scopoletin and Akt. Vasodilation caused by senkyunolide A and scopoletin was inhibited by uprosertib (Akt inhibitor) and eNOS/sGC/PKG axis inhibitors. This suggests that senkyunolide A and scopoletin relax coronary arteries through the Akt-eNOS-NO pathway. In addition, borneol induced endothelium-independent vasorelaxation of the coronary artery. The Kv channel inhibitor 4-AP, KCa2+ inhibitor TEA, and Kir inhibitor BaCl2 significantly inhibited the vasorelaxant effect of borneol in the coronary artery. In conclusion, the results show that Suxiao Jiuxin Pill protects the heart against acute myocardial infarction. | ||
546 | |a EN | ||
690 | |a Suxiao Jiuxin Pill | ||
690 | |a senkyunolide a | ||
690 | |a scopoletin | ||
690 | |a borneol | ||
690 | |a vasorelaxation | ||
690 | |a acute myocardial infarction | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 14 (2023) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1104243/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/ff899674a08b4c1c94964d0acdedbd07 |z Connect to this object online. |